Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03025984 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Texting for Diabetes

StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date: Dec 31, 2025 to Dec 31, 2026
    • Study completion date: Dec 31, 2026 to Dec 31, 2027
    v13
  2. Primary completion date: Dec 31, 2024 to Dec 31, 2025
    • Study completion date: Dec 31, 2025 to Dec 31, 2026
    • Eligibility criteria revised
    v12
  3. Primary completion date: Dec 31, 2023 to Dec 31, 2024
    • Study completion date: Dec 31, 2024 to Dec 31, 2025
    v11
  4. Primary completion date: Jul 31, 2022 to Dec 31, 2023v10 Show 4 more changesShow less
    • Trial status: Recruiting to Active, Not Recruiting
    • Enrollment target: estimated 250 to confirmed 185
    • Study completion date: Dec 31, 2022 to Dec 31, 2024
    • Site details revised
  5. Primary completion date: Aug 31, 2021 to Jul 31, 2022
    • Study completion date: Feb 28, 2022 to Dec 31, 2022
    v9
Show 7 earlier versionsHide 7 earlier versions
  1. Primary completion date: Dec 31, 2020 to Aug 31, 2021
    • Study completion date: Dec 31, 2021 to Feb 28, 2022
    v8
  2. Trial status: Suspended to Recruiting
    • Primary completion date: Feb 28, 2020 to Dec 31, 2020
    • Study completion date: Sep 30, 2020 to Dec 31, 2021
    • Site details revised
    v7
  3. Primary completion date: Feb 28, 2019 to Feb 28, 2020
    • Study completion date: Jun 1, 2019 to Sep 30, 2020
    v6
  4. Primary completion date: Jan 2018 to Feb 28, 2019
    • Study completion date: May 2018 to Jun 1, 2019
    v5
  5. Re-verified, no change to tracked fieldsv4
  6. Trial status: Recruiting to Suspended Sponsor's reason: On Internal Hold
    • Site details revised
    v3
  7. Primary endpoint revised
    • Eligibility criteria revised
    • Study description expanded, about 7 words
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
St. Louis University
22 trials monitored
See 1 trial at risk
Diabetes
5,087 trials monitored
See 222 trials at risk
Diabetes is a common complication of pregnancy that increases risks for both the mother and baby. Poorly controlled diabetes has been associated with very large babies, congenital heart defects, stillbirth, birth trauma, and maternal infections among other complications. Patients with diabetes in pregnancy require more frequent prenatal visits and fetal evaluation, and must shoulder the burden of mastering management of a complicated care regimen. With the ever-expanding world of technology, more healthcare practices are using cell phones, texting, and social media to interact with patients. Use of this technology has been successful in management of chronic diseases and as reminder systems. The investigators propose a randomized clinical trial to investigate patient adherence to recommended care regimen after intervention of a text message reminder and education system.
Trial Details
NCT Number NCT03025984
Lead Sponsor St. Louis University
Conditions
(from sponsor)		 Diabetes Mellitus
Related terms Diabetes Mellitus
Enrollment 185 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov